 | • レポートコード：MRC2-11QY01752 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインスリン有効成分のグローバル市場について調査・分析したレポートです。種類別（化学合成、動物抽出物）市場規模、用途別（動物インスリン、通常ヒトインスリン、インスリンアナログ）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インスリン有効成分の競争状況、市場シェア ・世界のインスリン有効成分市場：種類別市場規模 2015年-2020年（化学合成、動物抽出物） ・世界のインスリン有効成分市場：種類別市場規模予測 2021年-2026年（化学合成、動物抽出物） ・世界のインスリン有効成分市場：用途別市場規模 2015年-2020年（動物インスリン、通常ヒトインスリン、インスリンアナログ） ・世界のインスリン有効成分市場：用途別市場規模予測 2021年-2026年（動物インスリン、通常ヒトインスリン、インスリンアナログ） ・北米のインスリン有効成分市場分析：米国、カナダ ・ヨーロッパのインスリン有効成分市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインスリン有効成分市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインスリン有効成分市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインスリン有効成分市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novo Nordisk、Eli Lilly、Tong Hua Dong Bao Group、Wanbang Biopharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Insulin Active Pharmaceutical Ingredient Market
The global Insulin Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Insulin Active Pharmaceutical Ingredient Scope and Market Size
Insulin Active Pharmaceutical Ingredient market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Insulin Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Insulin Active Pharmaceutical Ingredient market is segmented into
Chemical Synthetics
Animal Extracts
Segment by Application, the Insulin Active Pharmaceutical Ingredient market is segmented into
Animal Insulin
Regular Human Insulin
Insulin Analogue
Regional and Country-level Analysis
The Insulin Active Pharmaceutical Ingredient market is analysed and market size information is provided by regions (countries).
The key regions covered in the Insulin Active Pharmaceutical Ingredient market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Insulin Active Pharmaceutical Ingredient Market Share Analysis
Insulin Active Pharmaceutical Ingredient market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Insulin Active Pharmaceutical Ingredient business, the date to enter into the Insulin Active Pharmaceutical Ingredient market, Insulin Active Pharmaceutical Ingredient product introduction, recent developments, etc.
The major vendors covered:
Novo Nordisk
Eli Lilly
Tong Hua Dong Bao Group
Wanbang Biopharmaceuticals
…
1 Study Coverage
1.1 Insulin Active Pharmaceutical Ingredient Product Introduction
1.2 Market Segments
1.3 Key Insulin Active Pharmaceutical Ingredient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Insulin Active Pharmaceutical Ingredient Market Size Growth Rate by Type
1.4.2 Chemical Synthetics
1.4.3 Animal Extracts
1.5 Market by Application
1.5.1 Global Insulin Active Pharmaceutical Ingredient Market Size Growth Rate by Application
1.5.2 Animal Insulin
1.5.3 Regular Human Insulin
1.5.4 Insulin Analogue
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Insulin Active Pharmaceutical Ingredient Market Size, Estimates and Forecasts
2.1.1 Global Insulin Active Pharmaceutical Ingredient Revenue 2015-2026
2.1.2 Global Insulin Active Pharmaceutical Ingredient Sales 2015-2026
2.2 Global Insulin Active Pharmaceutical Ingredient, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Insulin Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Insulin Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Insulin Active Pharmaceutical Ingredient Competitor Landscape by Players
3.1 Insulin Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.1 Insulin Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020)
3.1.2 Insulin Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2015-2020)
3.2 Insulin Active Pharmaceutical Ingredient Revenue by Manufacturers
3.2.1 Insulin Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Insulin Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Insulin Active Pharmaceutical Ingredient Revenue in 2019
3.2.5 Global Insulin Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Insulin Active Pharmaceutical Ingredient Price by Manufacturers
3.4 Insulin Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Insulin Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Insulin Active Pharmaceutical Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Insulin Active Pharmaceutical Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Insulin Active Pharmaceutical Ingredient Market Size by Type (2015-2020)
4.1.1 Global Insulin Active Pharmaceutical Ingredient Sales by Type (2015-2020)
4.1.2 Global Insulin Active Pharmaceutical Ingredient Revenue by Type (2015-2020)
4.1.3 Insulin Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Insulin Active Pharmaceutical Ingredient Market Size Forecast by Type (2021-2026)
4.2.1 Global Insulin Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Insulin Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Insulin Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Insulin Active Pharmaceutical Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Insulin Active Pharmaceutical Ingredient Market Size by Application (2015-2020)
5.1.1 Global Insulin Active Pharmaceutical Ingredient Sales by Application (2015-2020)
5.1.2 Global Insulin Active Pharmaceutical Ingredient Revenue by Application (2015-2020)
5.1.3 Insulin Active Pharmaceutical Ingredient Price by Application (2015-2020)
5.2 Insulin Active Pharmaceutical Ingredient Market Size Forecast by Application (2021-2026)
5.2.1 Global Insulin Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Insulin Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Insulin Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)
6 North America
6.1 North America Insulin Active Pharmaceutical Ingredient by Country
6.1.1 North America Insulin Active Pharmaceutical Ingredient Sales by Country
6.1.2 North America Insulin Active Pharmaceutical Ingredient Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Type
6.3 North America Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Application
7 Europe
7.1 Europe Insulin Active Pharmaceutical Ingredient by Country
7.1.1 Europe Insulin Active Pharmaceutical Ingredient Sales by Country
7.1.2 Europe Insulin Active Pharmaceutical Ingredient Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Type
7.3 Europe Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Insulin Active Pharmaceutical Ingredient by Region
8.1.1 Asia Pacific Insulin Active Pharmaceutical Ingredient Sales by Region
8.1.2 Asia Pacific Insulin Active Pharmaceutical Ingredient Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Type
8.3 Asia Pacific Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Application
9 Latin America
9.1 Latin America Insulin Active Pharmaceutical Ingredient by Country
9.1.1 Latin America Insulin Active Pharmaceutical Ingredient Sales by Country
9.1.2 Latin America Insulin Active Pharmaceutical Ingredient Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Type
9.3 Central & South America Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Insulin Active Pharmaceutical Ingredient by Country
10.1.1 Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales by Country
10.1.2 Middle East and Africa Insulin Active Pharmaceutical Ingredient Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Type
10.3 Middle East and Africa Insulin Active Pharmaceutical Ingredient Market Facts & Figures by Application
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Insulin Active Pharmaceutical Ingredient Products Offered
11.1.5 Novo Nordisk Related Developments
11.2 Eli Lilly
11.2.1 Eli Lilly Corporation Information
11.2.2 Eli Lilly Description and Business Overview
11.2.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eli Lilly Insulin Active Pharmaceutical Ingredient Products Offered
11.2.5 Eli Lilly Related Developments
11.3 Tong Hua Dong Bao Group
11.3.1 Tong Hua Dong Bao Group Corporation Information
11.3.2 Tong Hua Dong Bao Group Description and Business Overview
11.3.3 Tong Hua Dong Bao Group Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Products Offered
11.3.5 Tong Hua Dong Bao Group Related Developments
11.4 Wanbang Biopharmaceuticals
11.4.1 Wanbang Biopharmaceuticals Corporation Information
11.4.2 Wanbang Biopharmaceuticals Description and Business Overview
11.4.3 Wanbang Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Products Offered
11.4.5 Wanbang Biopharmaceuticals Related Developments
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Insulin Active Pharmaceutical Ingredient Products Offered
11.1.5 Novo Nordisk Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Insulin Active Pharmaceutical Ingredient Market Estimates and Projections by Region
12.1.1 Global Insulin Active Pharmaceutical Ingredient Sales Forecast by Regions 2021-2026
12.1.2 Global Insulin Active Pharmaceutical Ingredient Revenue Forecast by Regions 2021-2026
12.2 North America Insulin Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.2.1 North America: Insulin Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.2.2 North America: Insulin Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.2.3 North America: Insulin Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.3 Europe Insulin Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.3.1 Europe: Insulin Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.3.2 Europe: Insulin Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.3.3 Europe: Insulin Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Insulin Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Insulin Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Insulin Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Insulin Active Pharmaceutical Ingredient Market Size Forecast by Region (2021-2026)
12.5 Latin America Insulin Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.5.1 Latin America: Insulin Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.5.2 Latin America: Insulin Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.5.3 Latin America: Insulin Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Insulin Active Pharmaceutical Ingredient Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Insulin Active Pharmaceutical Ingredient Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Insulin Active Pharmaceutical Ingredient Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Insulin Active Pharmaceutical Ingredient Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Insulin Active Pharmaceutical Ingredient Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Insulin Active Pharmaceutical Ingredient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Insulin Active Pharmaceutical Ingredient Market Segments
Table 2. Ranking of Global Top Insulin Active Pharmaceutical Ingredient Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Active Pharmaceutical Ingredient Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Chemical Synthetics
Table 5. Major Manufacturers of Animal Extracts
Table 6. Global Insulin Active Pharmaceutical Ingredient Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Insulin Active Pharmaceutical Ingredient Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Insulin Active Pharmaceutical Ingredient Sales by Regions 2015-2020 (K MT)
Table 9. Global Insulin Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 10. Global Insulin Active Pharmaceutical Ingredient Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Insulin Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Insulin Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015-2020)
Table 13. Global Insulin Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Insulin Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Active Pharmaceutical Ingredient as of 2019)
Table 15. Insulin Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Insulin Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Insulin Active Pharmaceutical Ingredient Price (2015-2020) (USD/MT)
Table 18. Insulin Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Insulin Active Pharmaceutical Ingredient Product Type
Table 20. Date of International Manufacturers Enter into Insulin Active Pharmaceutical Ingredient Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Insulin Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 23. Global Insulin Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 24. Global Insulin Active Pharmaceutical Ingredient Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Insulin Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)
Table 26. Insulin Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Insulin Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 28. Global Insulin Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 29. North America Insulin Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 30. North America Insulin Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 31. North America Insulin Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Insulin Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 33. North America Insulin Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 34. North America Insulin Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 35. North America Insulin Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 36. North America Insulin Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 37. Europe Insulin Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 38. Europe Insulin Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 39. Europe Insulin Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Insulin Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 41. Europe Insulin Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 42. Europe Insulin Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 43. Europe Insulin Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 44. Europe Insulin Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Insulin Active Pharmaceutical Ingredient Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Insulin Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Insulin Active Pharmaceutical Ingredient Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Insulin Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Insulin Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Insulin Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Insulin Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Insulin Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 53. Latin America Insulin Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 54. Latin America Insulin Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Insulin Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Insulin Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 57. Latin America Insulin Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 58. Latin America Insulin Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 59. Latin America Insulin Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 60. Latin America Insulin Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Insulin Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Insulin Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Table 69. Novo Nordisk Corporation Information
Table 70. Novo Nordisk Description and Major Businesses
Table 71. Novo Nordisk Insulin Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Novo Nordisk Product
Table 73. Novo Nordisk Recent Development
Table 74. Eli Lilly Corporation Information
Table 75. Eli Lilly Description and Major Businesses
Table 76. Eli Lilly Insulin Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Eli Lilly Product
Table 78. Eli Lilly Recent Development
Table 79. Tong Hua Dong Bao Group Corporation Information
Table 80. Tong Hua Dong Bao Group Description and Major Businesses
Table 81. Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Tong Hua Dong Bao Group Product
Table 83. Tong Hua Dong Bao Group Recent Development
Table 84. Wanbang Biopharmaceuticals Corporation Information
Table 85. Wanbang Biopharmaceuticals Description and Major Businesses
Table 86. Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Wanbang Biopharmaceuticals Product
Table 88. Wanbang Biopharmaceuticals Recent Development
Table 89. Global Insulin Active Pharmaceutical Ingredient Sales Forecast by Regions (2021-2026) (K MT)
Table 90. Global Insulin Active Pharmaceutical Ingredient Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Insulin Active Pharmaceutical Ingredient Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Insulin Active Pharmaceutical Ingredient Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Insulin Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 94. North America: Insulin Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Insulin Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 96. Europe: Insulin Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Insulin Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026) (K MT)
Table 98. Asia Pacific: Insulin Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Insulin Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 100. Latin America: Insulin Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Insulin Active Pharmaceutical Ingredient Sales Forecast by Country (2021-2026) (K MT)
Table 102. Middle East and Africa: Insulin Active Pharmaceutical Ingredient Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Insulin Active Pharmaceutical Ingredient Players
Table 107. Insulin Active Pharmaceutical Ingredient Customers List
Table 108. Insulin Active Pharmaceutical Ingredient Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Active Pharmaceutical Ingredient Product Picture
Figure 2. Global Insulin Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 & 2026
Figure 3. Chemical Synthetics Product Picture
Figure 4. Animal Extracts Product Picture
Figure 5. Global Insulin Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 & 2026
Figure 6. Animal Insulin
Figure 7. Regular Human Insulin
Figure 8. Insulin Analogue
Figure 9. Insulin Active Pharmaceutical Ingredient Report Years Considered
Figure 10. Global Insulin Active Pharmaceutical Ingredient Market Size 2015-2026 (US$ Million)
Figure 11. Global Insulin Active Pharmaceutical Ingredient Sales 2015-2026 (K MT)
Figure 12. Global Insulin Active Pharmaceutical Ingredient Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Insulin Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)
Figure 14. Global Insulin Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 15. Global Insulin Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)
Figure 16. Global Insulin Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 17. Global Insulin Active Pharmaceutical Ingredient Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Insulin Active Pharmaceutical Ingredient Revenue in 2019
Figure 19. Insulin Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Insulin Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
Figure 21. Global Insulin Active Pharmaceutical Ingredient Sales Market Share by Type in 2019
Figure 22. Global Insulin Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)
Figure 23. Global Insulin Active Pharmaceutical Ingredient Revenue Market Share by Type in 2019
Figure 24. Global Insulin Active Pharmaceutical Ingredient Market Share by Price Range (2015-2020)
Figure 25. Global Insulin Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
Figure 26. Global Insulin Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 27. Global Insulin Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
Figure 28. Global Insulin Active Pharmaceutical Ingredient Revenue Market Share by Application in 2019
Figure 29. North America Insulin Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Insulin Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 32. North America Insulin Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 33. U.S. Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Insulin Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 38. North America Insulin Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 39. Europe Insulin Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Insulin Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 42. Europe Insulin Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 43. Germany Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Insulin Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 54. Europe Insulin Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 55. Asia Pacific Insulin Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Insulin Active Pharmaceutical Ingredient Sales Market Share by Region in 2019
Figure 58. Asia Pacific Insulin Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019
Figure 59. China Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Insulin Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 82. Asia Pacific Insulin Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 83. Latin America Insulin Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Insulin Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 86. Latin America Insulin Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 87. Mexico Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Insulin Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 94. Latin America Insulin Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 95. Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Insulin Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019
Figure 99. Turkey Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Insulin Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Insulin Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Insulin Active Pharmaceutical Ingredient Market Share by Type in 2019
Figure 106. Middle East and Africa Insulin Active Pharmaceutical Ingredient Market Share by Application in 2019
Figure 107. North America Insulin Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Insulin Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Insulin Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Insulin Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Insulin Active Pharmaceutical Ingredient Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
医薬品有効成分の世界市場（～2026年） Market Analysis and Insights: Global Active Pharma Ingredient Market The global Active Pharma Ingredient market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Active Pharma Ingredient Scope and Market Size Active Pharma Ingr…- CISインスリンの世界市場（～2026年） Insulin is a peptide hormone produced by beta cells of the pancreatic islets, which is considered to be the main anabolic hormone of the body. Russia is estimated to witness a significant growth over the next decade owing to the various subsidies provided by the local government. Market Analysis and…
- 糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…
- バイオシミラーインスリンの世界市場（～2026年） Biosimilars is a biological product designed to have similar active properties to the one that has been previously licensed and has no clinically significant differences in terms of safety and effectiveness. Biosimilars insulin is a type of biosimilars where it is indistinguishable to the reference …
- インスリンデテミルの世界市場（～2026年） Market Analysis and Insights: Global Insulin Detemir Market The global Insulin Detemir market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Insulin Detemir Scope and Market Size Insulin Detemir market is segmented by Type, …